Improving AAV vectors via chemical engineering using the AAV-Ligand conjugation platform (ALIGATER™)

被引:0
|
作者
Jordi, E. [1 ]
Savy, A. [1 ]
Kunalingam, L. [1 ]
Compere, D. [1 ]
Kara-Ali, K. [1 ]
Vidal, P. [1 ]
Brument, N. [1 ]
Mitchell, C. [1 ]
Lefevre, G. M. [1 ]
Francon, P. [1 ]
机构
[1] Coave Therapeut, Paris, France
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
P200
引用
收藏
页码:A111 / A112
页数:2
相关论文
共 12 条
  • [11] Targeting Photoreceptors via Intravitreal Delivery Using Novel, Capsid-Mutated AAV Vectors (vol 8, e62097, 2013)
    Kay, C. N.
    Ryals, R. C.
    Aslanidi, G., V
    Min, S. H.
    Ruan, Q.
    PLOS ONE, 2014, 9 (09):
  • [12] Evolution of Blood-Brain Barrier Penetrant AAV Capsids in Non-Human Primates Using a Multiplexed Transcription Dependent Capsid Engineering Platform
    Tiffany, Matthew R.
    Frias, Stephanye
    Andrews, Lori
    Nanjaraj, Ankitha
    Bendana, Yuri
    Darst, Russell
    Wist, Stephen
    Tran, Hung
    Kennard, Kenneth
    Mueller, Sarah
    Ojala, David
    Pooler, Amy
    MOLECULAR THERAPY, 2023, 31 (04) : 573 - 573